Pulse Biosciences is developing nsPFA technology for cardiac ablation to treat AFib and for ablating benign thyroid nodules.

Denmark aims to eradicate cervical cancer by 2040 thanks to a national HPV vaccination campaign and screening program, the ...

The US Food and Drug Administration (FDA) has granted approval for Innoblative Designs' investigational device exemption (IDE ...

WEB Medical, an orthopedic implant company focused on developing innovative implants that utilize its proprietary TRUSS Implant Technologytm, announced today that the company has surpassed the 100,000 ...

Abbott's Volt™ PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillation Pulsed field ablation – or PFA – uses high energy ...

His focus on safety and precision in the design and development process has made a lasting impact on the field, improving the efficiency of ablation procedures and leading to better patient outcomes.

Non-surgical ablation is crucial in patients with benign tumours since it helps maintain thyroid function and limits the necessity of more invasive therapy. Experts say mostly after the procedure, in ...

Lesions classified as CIN2/3 are considered to be precancerous and can progress to cervical cancer if left untreated. One treatment option for CIN2/3 lesions is the loop electrosurgical excision ...

Resources are needed to improve post-LEEP follow-up for women with margin positivity who require additional ablative/excisional procedures to reduce the cervical cancer burden in Botswana. Supported ...

If a woman is diagnosed with cervical cancer, treatment will depend on how far the cancer has progressed. In the early stages, surgery may be enough to remove the cancer. For more advanced cases ...